On July 29, 2026, the Federal Trade Commission (the “FTC”) filed a lawsuit against Hims, accusing the Company of sharing customers’ medical information with third-party advertisers. The FTC complaint accuses the Company of “deceptive and unlawful privacy practices,” including sharing sensitive details about patients’ health with Meta Platforms.
On this news, Hims’s stock price fell $4.32 per share, or 14.73%, to close at $25.00 on July 29, 2026.